News | Cardiovascular Ultrasound
The Human Animal Bond Research Initiative (HABRI) announced it has awarded a $44,000 grant to Duke University School of Medicine’s Division of Pediatric Cardiology for a new research study on the impact of therapy dogs on pediatric echocardiograms.
October 25, 2016
Feature | Implantable Cardioverter Defibrillator (ICD) | Dave Fornell
October 25, 2016 — St. Jude Medical is recalling 251,346 of its Fortify, Unify and Assura implantable cardioverter ...
October 25, 2016
News | Wearables
October 24, 2016 — Conventional smart clothing uses conductive fibers or rubber as sensing electrodes, and cardiac ...
October 24, 2016Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Cardiovascular Business | By John W. Meyer, MPH, FACHE
(Editor’s note: This is the second part of a two-part series on the proposed Medicare five-year demonstration for a ...
October 24, 2016
Technology | Atherectomy Devices
October 24, 2016 — Medtronic received U.S. Food and Drug Administration (FDA) 510(k) clearance for the HawkOne ...
October 24, 2016
Feature | Stents Bioresorbable | Dave Fornell
There has been a lot of interest in the interventional community regarding the Abbott Absorb Bioresorbable Vascular ...
October 20, 2016Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
October 20, 2016 — SentreHeart Inc. announced in late September the closing of a $35 million Series D round of financing ...
October 20, 2016
News | Atherectomy Devices
Avinger Inc. recently announced that the company has received expanded indications from the U.S. Food and Drug Administration (FDA) recognizing the Pantheris Lumivascular atherectomy system as a technology that can be used for both therapeutic and diagnostic purposes.
October 20, 2016
News | Congenital Heart
St. Jude Medical Inc. announced the launch of the ADO II AS (AMPLATZER Duct Occluder II Additional Sizes) pediatric clinical trial. The U.S. IDE clinical trial will evaluate the safety and effectiveness of the St. Jude Medical Amplatzer Duct Occluder II AS (ADO II AS), a first-of-its-kind device specifically designed for closure of the small patent ductus arteriosus (PDA).
October 19, 2016Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Cath Lab
Medtronic plc announced last week that it has notified customers of a voluntary recall of certain lots of its Pipeline embolization device, Alligator retrieval device and X-Celerator hydrophilic guidewire. The recall also includes the stylet containing UltraFlow flow directed micro catheters and Marathon flow directed micro catheters. These products are produced, marketed and sold by Medtronic's Neurovascular business, which is part of the Brain Therapies division in the company's Restorative Therapies Group.
October 18, 2016
Whitepapers | Inventory Management
As healthcare moves into the era of bundled payments, providers need to be especially focused on ensuring delivery of ...
October 18, 2016
News | Cardiovascular Ultrasound
Analogic Corp. announced last week that it will introduce its new premium cardiac imaging software for the bk3500 ultrasound system at the American College of Emergency Physicians (ACEP) Scientific Assembly, Oct. 16–19, 2016, in Las Vegas.
October 18, 2016Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology | SPECT-CT
At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), Siemens Healthineers will showcase an expanded version of xSPECT Quant, its established single-photon emission computed tomography (SPECT) quantification technology.
October 18, 2016
News | Vascular Closure Devices
October 18, 2016 — Abbott and St. Jude Medical Inc. announced today an agreement to sell certain products from their ...
October 18, 2016
Lantheus Holdings Inc. announced in late September that sub-analysis data from the first Phase 3 study of flurpiridaz F-18 for myocardial perfusion imaging (MPI) in patients undergoing exercise stress testing. The data was presented at the 21st annual scientific session of the American Society of Nuclear Cardiology (ASNC), Sept. 22-25 in Boca Raton, Fla.
October 17, 2016© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now